Diamonds and Dogs

2/4/25

Palantir Technologies (PLTR) jumps over 20% to all-time highs following strong earnings with no signs of deceleration in growth going forward. Palantir engages in the business of building and deploying AI software platforms that serve as the central operating systems for its customers. Palantir and their software are instrumental and embedded in the US government including the US military. Management said any boost in business from the Trump Presidential election has not been included in 2025 guidance.

Merck (MRK) takes a hit following earnings. Merck is down 10%, on track for its worst day in 17 years due to the drug company's softer-than-expected guidance and struggles with its HPV vaccine in China. Merck's blockbuster cancer drug Keytruda, saw a boost in sales by 19% $7.8 billion, ahead of the $7.6 billion. Merck also launched a hypertension drug, Winrevair for their animal health business.